ID I36RA_HUMAN Reviewed; 155 AA. AC Q9UBH0; A8K2I4; Q56AT9; Q7RTZ6; DT 08-NOV-2002, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 25-JAN-2012, entry version 97. DE RecName: Full=Interleukin-36 receptor antagonist protein; DE AltName: Full=FIL1 delta; DE AltName: Full=IL-1-related protein 3; DE Short=IL-1RP3; DE AltName: Full=Interleukin-1 HY1; DE Short=IL-1HY1; DE AltName: Full=Interleukin-1 delta; DE Short=IL-1 delta; DE AltName: Full=Interleukin-1 family member 5; DE Short=IL-1F5; DE AltName: Full=Interleukin-1 receptor antagonist homolog 1; DE Short=IL-1ra homolog 1; DE AltName: Full=Interleukin-1-like protein 1; DE Short=IL-1L1; GN Name=IL36RN; Synonyms=FIL1D, IL1F5, IL1HY1, IL1L1, IL1RP3; GN ORFNames=UNQ1896/PRO4342; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Placenta; RX MEDLINE=20092888; PubMed=10625660; DOI=10.1074/jbc.275.2.1169; RA Smith D.E., Renshaw B.R., Ketchem R.R., Kubin M., Garka K.E., RA Sims J.E.; RT "Four new members expand the IL-1 superfamily."; RL J. Biol. Chem. 275:1169-1175(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Fetal skin; RX MEDLINE=99443727; PubMed=10512743; DOI=10.1006/bbrc.1999.1440; RA Mulero J.J., Pace A.M., Nelken S.T., Loeb D.B., Correa T.R., RA Drmanac R., Ford J.E.; RT "IL1HY1: a novel interleukin-1 receptor antagonist gene."; RL Biochem. Biophys. Res. Commun. 263:702-706(1999). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Placenta; RX MEDLINE=20545212; PubMed=11093146; RX DOI=10.1002/1521-4141(200011)30:11<3299::AID-IMMU3299>3.0.CO;2-S; RA Barton J.L., Herbst R., Bosisio D., Higgins L., Nicklin M.J.H.; RT "A tissue specific IL-1 receptor antagonist homolog from the IL-1 RT cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities."; RL Eur. J. Immunol. 30:3299-3308(2000). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=21359532; PubMed=11466363; RA Debets R., Timans J.C., Homey B., Zurawski S., Sana T.R., Lo S., RA Wagner J., Edwards G., Clifford T., Menon S., Bazan J.F., RA Kastelein R.A.; RT "Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function RT as an antagonist and agonist of NF-kappa B activation through the RT orphan IL-1 receptor-related protein 2."; RL J. Immunol. 167:1440-1446(2001). RN [5] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=20318623; PubMed=10860666; DOI=10.1006/geno.2000.6184; RA Busfield S.J., Comrack C.A., Yu G., Chickering T.W., Smutko J.S., RA Zhou H., Leiby K.R., Holmgren L.M., Gearing D.P., Pan Y.; RT "Identification and gene organization of three novel members of the RT IL-1 family on human chromosome 2."; RL Genomics 66:213-216(2000). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX MEDLINE=21988050; PubMed=11991722; DOI=10.1006/geno.2002.6751; RA Nicklin M.J.H., Barton J.L., Nguyen M., Fitzgerald M.G., Duff W.G., RA Kornman K.; RT "A sequence-based map of the nine genes of the human interleukin-1 RT cluster."; RL Genomics 79:718-725(2002). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX MEDLINE=22887296; PubMed=12975309; DOI=10.1101/gr.1293003; RA Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., RA Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., RA Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., RA Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., RA Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J., RA Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A., RA Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H., RA Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D., RA Wood W.I., Godowski P.J., Gray A.M.; RT "The secreted protein discovery initiative (SPDI), a large-scale RT effort to identify novel human secreted and transmembrane proteins: a RT bioinformatics assessment."; RL Genome Res. 13:2265-2270(2003). RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Cervix; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., RA Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., RA Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., RA Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., RA Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., RA Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., RA Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., RA Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., RA Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., RA Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., RA Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., RA Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., RA Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., RA Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., RA Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., RA Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., RA Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., RA Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., RA Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., RA Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [9] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-47. RG SeattleSNPs variation discovery resource; RL Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases. RN [10] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., RA Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M., RA Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., RA Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J., RA Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C., RA Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J., RA Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A., RA Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K., RA Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M., RA Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., RA Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M., RA Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E., RA Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P., RA Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A., RA Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A., RA Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T., RA Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D., RA Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X., RA McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., RA Waterston R.H., Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 RT and 4."; RL Nature 434:724-731(2005). RN [11] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., RA Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., RA Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., RA Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., RA Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., RA Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., RA Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., RA Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [12] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [13] RP VARIANTS PSORP TRP-48 AND LEU-113. RX PubMed=21839423; DOI=10.1016/j.ajhg.2011.07.022; RA Onoufriadis A., Simpson M.A., Pink A.E., Di Meglio P., Smith C.H., RA Pullabhatla V., Knight J., Spain S.L., Nestle F.O., Burden A.D., RA Capon F., Trembath R.C., Barker J.N.; RT "Mutations in IL36RN/IL1F5 are associated with the severe episodic RT inflammatory skin disease known as generalized pustular psoriasis."; RL Am. J. Hum. Genet. 89:432-437(2011). RN [14] RP VARIANT PSORP PRO-27, AND CHARACTERIZATION OF VARIANT PSORP PRO-27. RX PubMed=21848462; DOI=10.1056/NEJMoa1013068; RA Marrakchi S., Guigue P., Renshaw B.R., Puel A., Pei X.Y., Fraitag S., RA Zribi J., Bal E., Cluzeau C., Chrabieh M., Towne J.E., Douangpanya J., RA Pons C., Mansour S., Serre V., Makni H., Mahfoudh N., Fakhfakh F., RA Bodemer C., Feingold J., Hadj-Rabia S., Favre M., Genin E., RA Sahbatou M., Munnich A., Casanova J.L., Sims J.E., Turki H., RA Bachelez H., Smahi A.; RT "Interleukin-36-receptor antagonist deficiency and generalized RT pustular psoriasis."; RL N. Engl. J. Med. 365:620-628(2011). CC -!- FUNCTION: Is a highly and a specific antagonist of the IL-1 CC receptor-related protein 2-mediated response to interleukin 1 CC family member 9 (IL1F9). Could constitute part of an independent CC signaling system analogous to interleukin-1 alpha (IL-1A), beta CC (IL-1B) receptor agonist and interleukin-1 receptor type I (IL- CC 1R1), that is present in epithelial barriers and takes part in CC local inflammatory response. CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- TISSUE SPECIFICITY: Predominantly expressed in keratinocytes but CC not in fibroblasts, endothelial cells or melanocytes. Detected CC also in the spleen, brain leukocyte and macrophage cell types. CC Increased in lesional psoriasis skin. CC -!- INDUCTION: By phorbol ester (PMA) and bacterial CC lipopolysaccharides (LPS) treatment in macrophage cell line. CC -!- DISEASE: Defects in IL36RN are the cause of psoriasis generalized CC pustular (PSORP) [MIM:614204]. PSORP is a life-threatening disease CC defined by repeated flares of sudden onset consisting of diffuse CC erythematous skin eruption characterized by rapid coverage with CC pustules, high-grade fever, asthenia, marked leukocytosis, and CC elevated serum levels of C-reactive protein. CC -!- SIMILARITY: Belongs to the IL-1 family. CC -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-1 entry; CC URL="http://en.wikipedia.org/wiki/Interleukin_1"; CC -!- WEB RESOURCE: Name=SeattleSNPs; CC URL="http://pga.gs.washington.edu/data/il1f5/"; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AF201830; AAF25210.1; -; mRNA. DR EMBL; AF186094; AAF02757.1; -; mRNA. DR EMBL; AJ242737; CAB59822.1; -; mRNA. DR EMBL; AJ242738; CAB59823.1; -; mRNA. DR EMBL; AJ271338; CAB67704.1; -; Genomic_DNA. DR EMBL; AF216693; AAF76981.1; -; Genomic_DNA. DR EMBL; AF230377; AAF91274.1; -; mRNA. DR EMBL; BN000002; CAD29877.1; -; Genomic_DNA. DR EMBL; AY359117; AAQ89475.1; -; mRNA. DR EMBL; AK290249; BAF82938.1; -; mRNA. DR EMBL; AY972853; AAX59031.1; -; Genomic_DNA. DR EMBL; AC016724; AAY14990.1; -; Genomic_DNA. DR EMBL; CH471217; EAW73617.1; -; Genomic_DNA. DR EMBL; BC024747; AAH24747.1; -; mRNA. DR IPI; IPI00017500; -. DR PIR; JC7104; JC7104. DR RefSeq; NP_036407.1; NM_012275.2. DR RefSeq; NP_775262.1; NM_173170.1. DR UniGene; Hs.516301; -. DR ProteinModelPortal; Q9UBH0; -. DR SMR; Q9UBH0; 2-155. DR IntAct; Q9UBH0; 4. DR MINT; MINT-1194342; -. DR STRING; Q9UBH0; -. DR DMDM; 25008600; -. DR PRIDE; Q9UBH0; -. DR Ensembl; ENST00000346807; ENSP00000259212; ENSG00000136695. DR Ensembl; ENST00000393200; ENSP00000376896; ENSG00000136695. DR GeneID; 26525; -. DR KEGG; hsa:26525; -. DR UCSC; uc002tis.1; human. DR CTD; 26525; -. DR GeneCards; GC02P113817; -. DR H-InvDB; HIX0002388; -. DR HGNC; HGNC:15561; IL36RN. DR HPA; HPA034542; -. DR MIM; 605507; gene. DR MIM; 614204; phenotype. DR neXtProt; NX_Q9UBH0; -. DR PharmGKB; PA38388; -. DR eggNOG; prNOG18290; -. DR GeneTree; ENSGT00530000062899; -. DR HOGENOM; HBG282870; -. DR HOVERGEN; HBG052099; -. DR InParanoid; Q9UBH0; -. DR OMA; SVVPNRS; -. DR OrthoDB; EOG4MKNHG; -. DR PhylomeDB; Q9UBH0; -. DR NextBio; 48854; -. DR ArrayExpress; Q9UBH0; -. DR Bgee; Q9UBH0; -. DR CleanEx; HS_IL1F5; -. DR Genevestigator; Q9UBH0; -. DR GermOnline; ENSG00000136695; Homo sapiens. DR GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW. DR GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW. DR GO; GO:0005152; F:interleukin-1 receptor antagonist activity; TAS:ProtInc. DR InterPro; IPR008996; Cytokine_IL1-like. DR InterPro; IPR003297; IL_rcpt_IL1RA. DR InterPro; IPR020877; Interleukin-1_CS. DR InterPro; IPR000975; Interleukin_1. DR KO; K05483; -. DR Pfam; PF00340; IL1; 1. DR PRINTS; PR00264; INTERLEUKIN1. DR PRINTS; PR01360; INTRLEUKIN1X. DR SMART; SM00125; IL1; 1. DR SUPFAM; SSF50353; Cytok_IL1_like; 1. DR PROSITE; PS00253; INTERLEUKIN_1; 1. PE 1: Evidence at protein level; KW Complete proteome; Cytokine; Disease mutation; Disulfide bond; KW Polymorphism; Reference proteome; Secreted. FT CHAIN 1 155 Interleukin-36 receptor antagonist FT protein. FT /FTId=PRO_0000153642. FT DISULFID 8 154 By similarity. FT VARIANT 27 27 L -> P (in PSORP; expression of the FT protein is severely impaired compared to FT wild-type; the mutant protein is FT substantially less able to inhibit IL1RL2 FT signaling than wild-type). FT /FTId=VAR_066646. FT VARIANT 47 47 N -> S (in dbSNP:rs28938777). FT /FTId=VAR_023239. FT VARIANT 48 48 R -> W (in PSORP). FT /FTId=VAR_066647. FT VARIANT 113 113 S -> L (in PSORP). FT /FTId=VAR_066648. SQ SEQUENCE 155 AA; 16962 MW; B96DB5EFA2612E25 CRC64; MVLSGALCFR MKDSALKVLY LHNNQLLAGG LHAGKVIKGE EISVVPNRWL DASLSPVILG VQGGSQCLSC GVGQEPTLTL EPVNIMELYL GAKESKSFTF YRRDMGLTSS FESAAYPGWF LCTVPEADQP VRLTQLPENG GWNAPITDFY FQQCD //